Judging form the chart it appears that things have gotten somewhat oversold and trading at around .40 is showing some bouyancy with a little more than average trading volume. I think RBM needs another financing but at this level it would be very unopportune, it often appears that penny stocks are manipulated to facilitate private placements. Hopefully we will see a reversal in the coming week and recovering to hifher price before this happens. Current cash burn rate is now over $1mil. a month and with the begining of commercial production to meet the needs of 3m and Roche will likely cause this figure to increase even further in the next few months. Everything is in place for this company to progress all we need is revenue to cover expenses. This is the last milestone and I believe it will be achieved. I remain positive on purchasing and holding these shares.

~~ dimar